Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVRI | Common Stock | Options Exercise | $138K | +19.4K | +1.98% | $7.09 | 1M | Aug 16, 2022 | Direct | F1 |
transaction | EVRI | Common Stock | Sale | -$408K | -19.4K | -1.94% | $21.00 | 982K | Aug 16, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVRI | Stock Option | Options Exercise | $0 | -19.4K | -100% | $0.00* | 0 | Aug 16, 2022 | Common Stock | 19.4K | $7.09 | Direct | F3 |
Id | Content |
---|---|
F1 | The transaction(s) reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on May 19, 2022 for options originally granted on March 6, 2013 that would have expired within the next seven months. |
F2 | The shares were sold in multiple transactions at a price of $21.00. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction at the price set forth in this footnote. |
F3 | Represents an option to purchase 19,424 shares of the Company's common stock, which vested periodically over a period of four years following the date of grant. |